Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1 USD | -1.96% | -3.85% | -27.54% |
30/04 | In8bio, Inc. Doses First Patient in Phase 2 Clinical Trial of Inb-400 in Newly Diagnosed Glioblastoma | CI |
10/04 | Top Premarket Gainers | MT |
- Stock Market
- Equities
- INAB Stock
- News IN8bio, Inc.